Assessing tumor response after loco-regional liver cancer therapies: the role of 3D MRI

References

• Siegel R, Ma J, Zou Z, Jemal A. Cancer statistics, 2014. CA Cancer J Clin 2014;64(1):9-29
   PubMed Web of Science ®Google Scholar
• Shinagare AB, Jagannathan JP, Krajewski KM, Ramaiya NH. Liver metastases in the era of molecular targeted therapy: new faces of treatment response. AJR Am J Roentgenol 2013;201(1):W15-28
   PubMed Web of Science ®Google Scholar
• Johnston FM, Mavros MN, Herman JM, Pawlik TM. Local therapies for hepatic metastases. J Natl Compr Canc Netw 2013;11(2):153-60
   PubMedGoogle Scholar
• Benson AB3rd, Abrams TA, Ben-Josef E, et al. NCCN clinical practice guidelines in oncology: hepatobiliary cancers. J Natl Compr Canc Netw 2009;7(4):350-91
   PubMed Web of Science ®Google Scholar
• Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999;19(3):329-38
   PubMed Web of Science ®Google Scholar
• Lewandowski RJ, Geschwind JF, Liapi E, Salem R. Transcatheter intraarterial therapies: rationale and overview. Radiology 2011;259(3):641-57
   PubMed Web of Science ®Google Scholar
• Anderson JR, Cain KC, Gelber RD. Analysis of survival by tumor response and other comparisons of time-to-event by outcome variables. J Clin Oncol 2008;26(24):3913-15
   PubMed Web of Science ®Google Scholar
• Riaz A, Memon K, Miller FH, et al. Role of the EASL, RECIST, and WHO response guidelines alone or in combination for hepatocellular carcinoma: radiologic-pathologic correlation. J Hepatol 2011;54(4):695-704
   PubMed Web of Science ®Google Scholar
• Egger ME, Cannon RM, Metzger TL, et al. Assessment of chemotherapy response in colorectal liver metastases in patients undergoing hepatic resection and the correlation to pathologic residual viable tumor. J Am Coll Surg 2013;216(4):845-56. discussion 856 847
   Google Scholar
• Bonekamp D, Bonekamp S, Halappa VG, et al. Interobserver agreement of semi-automated and manual measurements of functional MRI metrics of treatment response in hepatocellular carcinoma. Eur J Radiol 2013;83(3):487-96
   Google Scholar
• Bonekamp S, Jolepalem P, Lazo M, et al. Hepatocellular carcinoma: response to TACE assessed with semiautomated volumetric and functional analysis of diffusion-weighted and contrast-enhanced MR imaging data. Radiology 2011;260(3):752-61
   PubMed Web of Science ®Google Scholar
• Grady L. Random walks for image segmentation. IEEE Trans Pattern Anal Mach Intell 2006;28(11):1768-83
   PubMed Web of Science ®Google Scholar
• Rothe JH, Grieser C, Lehmkuhl L, et al. Size determination and response assessment of liver metastases with computed tomography--comparison of RECIST and volumetric algorithms. Eur J Radiol 2013;82(11):1831-9
   PubMed Web of Science ®Google Scholar
• Lin M, Pellerin O, Bhagat N, et al. Quantitative and volumetric European association for the study of the liver and response evaluation criteria in solid tumors measurements: feasibility of a semiautomated software method to assess tumor response after transcatheter arterial chemoembolization. J Vasc Interv Radiol 2012;23(12):1629-37
   PubMed Web of Science ®Google Scholar
• Chapiro J WL, Lin M, et al. A radiological-pathological analysis of contrast-enhanced and diffusion-weighted MRI in patients with HCC after TACE – testing the diagnostic accuracy of 3D quantitative image analysis. Radiology 2014; [Epub ahead of print]
   Google Scholar
• Tacher V, Lin M, Chao M, et al. Semiautomatic volumetric tumor segmentation for hepatocellular carcinoma: comparison between C-arm cone beam computed tomography and MRI. Acad Radiol 2013;20(4):446-52
   PubMed Web of Science ®Google Scholar
• Pellerin O, Lin M, Bhagat N, et al. Comparison of semi-automatic volumetric VX2 hepatic tumor segmentation from cone beam CT and multi-detector CT with histology in rabbit models. Acad Radiol 2013;20(1):115-21
   PubMed Web of Science ®Google Scholar
• Shim JH, Han S, Shin YM, et al. Optimal measurement modality and method for evaluation of responses to transarterial chemoembolization of hepatocellular carcinoma based on enhancement criteria. J Vasc Interv Radiol 2013;24(3):316-25
   PubMed Web of Science ®Google Scholar
• Thirion JP. Image matching as a diffusion process: an analogy with Maxwell’s demons. Med Image Anal 1998;2(3):243-60
   PubMedGoogle Scholar
• Sotiras A, Davatzikos C, Paragios N. Deformable medical image registration: a survey. IEEE Trans Med Imaging 2013;32(7):1153-90
   PubMed Web of Science ®Google Scholar
• Choi JW, Lee JM, Kim SJ, et al. Hepatocellular carcinoma: imaging patterns on gadoxetic acid-enhanced MR Images and their value as an imaging biomarker. Radiology 2013;267(3):776-86
   PubMedGoogle Scholar
• European Association For The Study Of The Liver; European Organisation For Research And Treatment Of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56(4):908-43
   PubMed Web of Science ®Google Scholar
• Lencioni R, Llovet JM. Modified RECIST (mRECIST) assessment for hepatocellular carcinoma. Semin Liver Dis 2010;30(1):52-60
   PubMed Web of Science ®Google Scholar
• Duran R, Chapiro J, Frangakis C, et al. Uveal melanoma metastatic to the liver: the role of quantitative volumetric contrast-enhanced MR imaging in the assessment of early tumor response after transarterial chemoembolization. Transl Oncol 2014;7(4):447-55
   PubMed Web of Science ®Google Scholar
• Gowdra Halappa V, Corona-Villalobos CP, Bonekamp S, et al. Neuroendocrine liver metastasis treated by using intraarterial therapy: volumetric functional imaging biomarkers of early tumor response and survival. Radiology 2013;266(2):502-13
   PubMed Web of Science ®Google Scholar
• Halappa VG, Bonekamp S, Corona-Villalobos CP, et al. Intrahepatic cholangiocarcinoma treated with local-regional therapy: quantitative volumetric apparent diffusion coefficient maps for assessment of tumor response. Radiology 2012;264(1):285-94
   PubMed Web of Science ®Google Scholar
• Li Z, Bonekamp S, Halappa VG, et al. Islet cell liver metastases: assessment of volumetric early response with functional MR imaging after transarterial chemoembolization. Radiology 2012;264(1):97-109
   Google Scholar
• Colagrande S, Carbone SF, Carusi LM, et al. Magnetic resonance diffusion-weighted imaging: extraneurological applications. Radiol Med (Torino) 2006;111(3):392-419
   Google Scholar
• Wagner M, Doblas S, Daire JL, et al. Diffusion-weighted MR imaging for the regional characterization of liver tumors. Radiology 2012;264(2):464-72
   Google Scholar
• Schmid-Tannwald C, Jiang Y, Dahi F, et al. Diffusion-weighted MR imaging of focal liver lesions in the left and right lobes: is there a difference in ADC values? Acad Radiol 2013;20(4):440-5
   Google Scholar
• Bonekamp S, Li Z, Geschwind JF, et al. Unresectable Hepatocellular Carcinoma: MR Imaging after Intraarterial Therapy. Part I. Identification and Validation of Volumetric Functional Response Criteria. Radiology 2013;268(2):420-30
   PubMed Web of Science ®Google Scholar
• Bonekamp S, Halappa VG, Geschwind JF, et al. Unresectable hepatocellular carcinoma: MR imaging after intraarterial therapy. Part II. Response stratification using volumetric functional criteria after intraarterial therapy. Radiology 2013;268(2):431-9
   Google Scholar
• Wang Z, Lin M, Lesage D, et al. Three-dimensional Evaluation of Lipiodol Retention in HCC after Chemoembolization: a Quantitative Comparison between CBCT and MDCT. Acad Radiol 2014;21(3):393-9
   PubMed Web of Science ®Google Scholar